secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0001437749-23-011241
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q1: revenue $31.9M (+5.1%), net loss $0.3M due to ransomware disruption
--------------------------------------------------------------------------------

- Revenue $31.9M, +5.1% YoY; operating income breakeven vs loss $0.3M last year.
- Net loss $0.3M ($0.02/share) vs net loss $0.2M ($0.01/share) in Q1 2022.
- Ransomware attack discovered Jan 25, 2023; no ransom paid; $0.1M cyber insurance deductible recorded.
- Gov/defense sales +24.7%; Communications Systems sales +181.8% to $3.4M on vehicle-amplifier adaptor order.
- Total backlog $108.1M, with $96.1M shippable in 9 months, up 30.2% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774923011241/0001437749-23-011241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774923011241/ulbi20230426_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-011241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer